Dimension Therapeutics, Inc.
SEC CIK 1592288 · DMTX · last insider filing 2017-11-09
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Migausky George V | Director | filed 2015 - 2017 |
| Gemayel Georges | Director | filed 2015 - 2017 |
| Colowick Alan | Director | filed 2015 - 2017 |
| Morris Arlene | Director | filed 2015 - 2017 |
| Dybbs Michael | Director | filed 2015 - 2017 |
| Jenkins Annalisa | Director · President and CEO | filed 2015 - 2017 |
| Hohneker John | Director | filed 2017 - 2017 |
| Gupta Rishi | Director | filed 2015 - 2016 |
| Isaly Samuel D | Director | filed 2015 - 2015 |
| Orbimed Advisors LLC | Director | filed 2015 - 2015 |
| Orbimed Capital GP V LLC | Director | filed 2015 - 2015 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Thistle Mary | Chief Operating Officer | filed 2015 - 2017 |
| Crombez Eric | Chief Medical Officer | filed 2015 - 2017 |
| Wadsworth Samuel C. | Chief Scientific Officer | filed 2015 - 2017 |
| Franchi Jean M. | Chief Financial Officer | filed 2015 - 2017 |
| Clark K. Reed | See Remarks | filed 2015 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.